These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 28991374)
21. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related]
22. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA. Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399 [TBL] [Abstract][Full Text] [Related]
23. SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis. Jiang K; Liu P; Xu H; Liang D; Fang K; Du S; Cheng W; Ye L; Liu T; Zhang X; Gong P; Shao S; Wang Y; Meng S Oncogene; 2020 Jul; 39(27):5015-5030. PubMed ID: 32523092 [TBL] [Abstract][Full Text] [Related]
24. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer. Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471 [TBL] [Abstract][Full Text] [Related]
25. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers. Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236 [TBL] [Abstract][Full Text] [Related]
26. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576 [TBL] [Abstract][Full Text] [Related]
27. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184 [TBL] [Abstract][Full Text] [Related]
28. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer. Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196 [TBL] [Abstract][Full Text] [Related]
29. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233 [TBL] [Abstract][Full Text] [Related]
30. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634 [TBL] [Abstract][Full Text] [Related]
31. Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation. Gao J; Zhang HP; Sun YH; Guo WZ; Li J; Tang HW; Guo DF; Zhang JK; Shi XY; Yu DS; Zhang XD; Wen PH; Shi JH; Zhang SJ Cancer Lett; 2020 Jul; 482():8-18. PubMed ID: 32278815 [TBL] [Abstract][Full Text] [Related]
32. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
33. Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy. Vici P; Ercolani C; Di Benedetto A; Pizzuti L; Di Lauro L; Sperati F; Terrenato I; Gamucci T; Natoli C; Di Filippo F; Botti C; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M J Exp Clin Cancer Res; 2016 Apr; 35():62. PubMed ID: 27039292 [TBL] [Abstract][Full Text] [Related]
34. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
35. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750 [TBL] [Abstract][Full Text] [Related]
36. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K Elife; 2021 Aug; 10():. PubMed ID: 34463254 [TBL] [Abstract][Full Text] [Related]
37. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
38. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells. Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456 [TBL] [Abstract][Full Text] [Related]
39. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258 [TBL] [Abstract][Full Text] [Related]
40. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells. Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]